For decades, animals have served as the default for drug testing, but the biological divide between species is proving costly. Currently, only about 10 percent of drugs that enter human trials receive ...

In the closing of the recent trading day, Astera Labs, Inc. (ALAB) stood at $144.67, denoting a -8.74% move from the ...

A groundbreaking multi-stakeholder report reveals that transitioning to Non-Animal Methods (NAMs) can reduce drug development ...

Plus, the debate around congressionally approved federal broadband funding continues, a report highlights access barriers for government services, a Massachusetts tool shows progress on broadband, and ...

Major equities indexes closed mixed on a busy earnings Wednesday, with technology shares pulling the Nasdaq and S&P 500 lower ...

Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and ...

Here’s exactly how to enable it and protect your data.

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

This week’s report examines how quantum computing, nanofabrication, and precision measurement are laying the groundwork for industrial adoption.

Hijacking web traffic is an old tactic for threat actors. In fact David Shipley, head of Canadian security awareness training ...

Sources told Bloomberg late Thursday that the startup, which is led by AI pioneer Fei-Fei Li, could receive a valuation of $5 ...

Citing RPwD Act, Court of Chief Commissioner for PwDs has directed full compliance with accommodations suggested in medical ...